Work

Characterizing Sensitivity to Vincristine, Irinotecan, and Telomerase-targeted Therapy in Diffuse Anaplastic Wilms Tumor Patient-derived Xenografts☆

Year: 2024

Type: article

Source: Journal of Pediatric Surgery

DOI: 10.1016/j.jpedsurg.2024.162122

Authors: Daniel B. Gehle, Carolyn M. Jablonowski, Prahalathan Pichavaram, Shivendra Singh, Mary A. Woolard, Christopher L. Morton, Catherine A. Billups, Andrew M. Davidoff, Jun Yang, Andrew J. Murphy

Institution: St. Jude Children's Research Hospital

Language: English

Topic: Renal and related cancers

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: St. Jude Children's Research Hospital, American Lebanese Syrian Associated Charities, National Institutes of Health, National Cancer Institute

Awards: Development of small molecules to target KDM4B, G4256527632, G4835394958, G5775726095, EXPLORE AND TARGET THE EPIGENETIC VULNERABILITY OF PAX3-FOXO1-DRIVEN RHABDOMYOSARCOMA, Cancer Center Support Grant (CCSG), WT1 as an oncogene and therapeutic target in anaplastic Wilms tumor

OpenAlex ID: W4405801631

FWCI:

Cites: 48

Cited by:

Related to: 10